vancomycin has been researched along with Cystic Fibrosis in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.50) | 18.7374 |
1990's | 2 (5.00) | 18.2507 |
2000's | 5 (12.50) | 29.6817 |
2010's | 21 (52.50) | 24.3611 |
2020's | 11 (27.50) | 2.80 |
Authors | Studies |
---|---|
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Esquivel, MD; Finklea, JD; Monogue, ML; Sanders, JM; Smith, GS | 1 |
Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH | 1 |
Bhakta, Z; Gray, K; Leclair, L; Lindley, B; Watanabe, A; Young, DC | 1 |
Autry, E; Kormelink, L; Kuhn, R; Mitchell, B; Schadler, A | 1 |
Ceppe, A; Conlon, BP; Lu, KY; Muhlebach, MS; Velez, AZ; Wagner, NJ | 1 |
Bio, L; Brockmeyer, JM; Frymoyer, A; Schwenk, HT | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Frederick, CA; Fusco, NM; Meaney, CJ; Prescott, WA | 1 |
Hofmann, T; Jouhikainen, T; Lord, J; Waterer, G | 1 |
Benner, K; Branstetter, J; Crowder, C; Searcy, H; Troxler, B; Yarbrough, A | 1 |
Autry, EB; Beckman, EJ; Gardner, BM; Kuhn, RJ; Saad, A; Schadler, A; Studtmann, AE; Wurth, MA; Young, MR | 1 |
LeCleir, LK; Pettit, RS | 1 |
O'Toole, GA; Orazi, G | 1 |
Duman, D; Francisconi, R; Frederick, CA; Fusco, NM; Meaney, CJ; Prescott, WA | 1 |
Esther, CR; McKinzie, CJ; Vece, TJ | 1 |
Amin, RW; Guttmann, RP; Harris, QR; Thomas, JW | 1 |
Bogdan, C; Kiefer, A; Melichar, VO | 1 |
Fusco, NM; Meaney, CJ; Prescott, WA | 1 |
Boyle, MP; Chmiel, JF; Dasenbrook, EC; Dezube, R; Diener-West, M; Jennings, MT; Rykiel, M | 1 |
Bernstein, AT; Esther, CR; Goralski, JL; Leigh, MW; McKinzie, CJ | 1 |
Ampofo, K; Frymoyer, A; Hersh, AL; Liu, X; Lubsch, L; Olson, J; Rashid, J; Sherwin, CMT; Stockmann, C; Wang, Y; Young, DC; Zobell, JT | 1 |
Ampofo, K; Lubsch, L; Noyes, BE; Olson, J; Sherwin, CM; Spigarelli, MG; Stockmann, C; Young, DC; Zobell, JT | 1 |
Boyle, MP; Callahan, KA; Dasenbrook, EC; Jennings, MT; Weaver, D | 1 |
Ampofo, K; Chin, MJ; Dasenbrook, E; Epps, KL; Marshall, BC; Montague, M; Olson, J; Young, DC; Zobell, JT | 1 |
Fusco, NM; Prescott, WA; Toussaint, KA | 1 |
Durham, SH; Eiland, LS; Garza, KB | 1 |
Feilcke, M; Forstner, M; Griese, M; Hector, A; Hengst, M; Kappler, M; Kröner, C; Naehrig, S; Nagel, F; Pawlita, I; Ripper, J; von Both, U | 1 |
Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS | 1 |
Barker, HC; Bilton, D; Haworth, CS; Roberts, P; Williams, D | 1 |
Feola, DJ; Hayes, D; Mullett, TW; Murphy, BS | 1 |
Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L | 1 |
Fung, L | 1 |
Jamerson, PA; Wilson, K | 1 |
Brown, D; Heaf, DP; Hughes, J; Solís, A; Van Saene, HK | 1 |
Chu, C; Greenberg, DP; Hussain, SZ; Khan, S; Orenstein, D | 1 |
Knowles, MR; Michalets, EL; Pleasants, RA; Rehm, JR; Samuelson, WM; Williams, DM | 1 |
Baquero, F; Cantón, R; Escobar, H; Máiz, L; Mir, N | 1 |
Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S | 1 |
Kuriyama, S; Panosian, C | 1 |
3 review(s) available for vancomycin and Cystic Fibrosis
Article | Year |
---|---|
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
Topics: Acetamides; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2015 |
Respiratory pharmacology. Antibiotics. II. Aminoglycosides, polymyxins, vancomycin, trimethoprim-sulfamethoxazole, and pentamidine.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cystic Fibrosis; Drug Combinations; Drug Resistance, Microbial; Humans; Pentamidine; Pneumonia; Polymyxins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
5 trial(s) available for vancomycin and Cystic Fibrosis
Article | Year |
---|---|
Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Patient Safety; Powders; Staphylococcal Infections; Vancomycin | 2020 |
Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Cystic Fibrosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nebulizers and Vaporizers; Remission Induction; Research Design; Rifampin; Staphylococcal Infections; Vancomycin | 2014 |
Comparison of central venous catheter and peripheral vein samples of antibiotics in children with cystic fibrosis.
Topics: Adolescent; Catheterization, Central Venous; Catheterization, Peripheral; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; Drug Monitoring; Female; Hospitals, Pediatric; Humans; Male; Sensitivity and Specificity; Specimen Handling; Tobramycin; Vancomycin | 2013 |
Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
Topics: Adult; Anti-Bacterial Agents; Bayes Theorem; Cystic Fibrosis; Female; Humans; Male; Respiratory Tract Infections; Vancomycin | 1996 |
32 other study(ies) available for vancomycin and Cystic Fibrosis
Article | Year |
---|---|
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Cystic Fibrosis; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2022 |
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2022 |
Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Hominidae; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Area Under Curve; Child; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2023 |
Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2023 |
Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Child; Cystic Fibrosis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2023 |
Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Cystic Fibrosis; Disease Progression; Female; Hospitalization; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Respiratory Function Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2020 |
Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult | 2020 |
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Female; Humans; Incidence; Infant; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult | 2020 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Topics: Anti-Bacterial Agents; Biofilms; Biological Factors; Cells, Cultured; Cystic Fibrosis; Humans; Hypoxia; Microbial Interactions; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 2017 |
Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Cohort Studies; Cystic Fibrosis; Female; Humans; Linear Models; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multivariate Analysis; Respiratory Function Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult | 2017 |
Continuous vancomycin in a pediatric cystic fibrosis patient.
Topics: Anti-Bacterial Agents; Child; Cystic Fibrosis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2018 |
Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Infant; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Pharmacokinetic Monitoring of Vancomycin in Cystic Fibrosis: Is It Time to Move Past Trough Concentrations?
Topics: Adolescent; Area Under Curve; Child; Cystic Fibrosis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2019 |
Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Cross Infection; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2018 |
An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
Topics: Adolescent; Area Under Curve; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pharmacokinetics; Vancomycin | 2019 |
Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Nonlinear Dynamics; Staphylococcal Infections; Tissue Distribution; Vancomycin | 2013 |
Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Child; Cross-Sectional Studies; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Health Care Surveys; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Practice Patterns, Physicians'; Rifampin; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infusions, Intravenous; Male; Patient Admission; Retrospective Studies; Vancomycin | 2016 |
Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2016 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin | 2017 |
Clostridium difficile pancolitis in adults with cystic fibrosis.
Topics: Adult; Clostridioides difficile; Cystic Fibrosis; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Steroids; Vancomycin | 2008 |
Aerosolized vancomycin for the treatment of MRSA after lung transplantation.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Lung Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Staphylococcal Infections; Vancomycin | 2010 |
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin | 2013 |
Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
Topics: Adolescent; Anti-Bacterial Agents; Child, Preschool; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.
Topics: Administration, Topical; Anti-Bacterial Agents; Carrier State; Cephradine; Child; Cystic Fibrosis; Female; Hand Disinfection; Humans; Infection Control; Male; Methicillin Resistance; Oropharynx; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Clostridium difficile colitis in children with cystic fibrosis.
Topics: Adolescent; Clostridioides difficile; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Humans; Male; Tomography, X-Ray Computed; Vancomycin | 2004 |
Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Child; Cystic Fibrosis; Humans; Lung Diseases; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin | 2002 |